Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 38430-55-6 | MDL No. : | MFCD00013241 |
Formula : | C11H12O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GLOAPLPTWAXAIG-UHFFFAOYSA-N |
M.W : | 192.21 | Pubchem ID : | 600911 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.27 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 52.72 |
TPSA : | 43.37 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.12 cm/s |
Log Po/w (iLOGP) : | 2.27 |
Log Po/w (XLOGP3) : | 1.9 |
Log Po/w (WLOGP) : | 2.07 |
Log Po/w (MLOGP) : | 1.88 |
Log Po/w (SILICOS-IT) : | 2.43 |
Consensus Log Po/w : | 2.11 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.28 |
Solubility : | 1.0 mg/ml ; 0.00523 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.43 |
Solubility : | 0.708 mg/ml ; 0.00368 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.22 |
Solubility : | 0.117 mg/ml ; 0.000607 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.37 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With 1,8-diazabicyclo[5.4.0]undec-7-ene; at 80℃; under 760.051 Torr; for 6h; | General procedure: The catalytic reactions were carried out in a 10 mL reaction flask and fitted with condenser and carbon monoxide balloon. In a typical run, a catalyst containing 1.0 mol% Pd, aryl iodide (0.5 mmol) and DBU (1.5 mmol) were added to solvent and allowed to react under CO atmosphere at 80 C temperature for 6-10 h. After the reaction,the flask was cooled to room temperature and carbon monoxide balloon was removed. The reaction mixture was then centrifuged and the clear supernatant was analyzed with GC by using n-butanol as an internal standard. For the study of substrate scope, after completion of the reaction, the catalyst was centrifuged and extracted with copious ethanol. The obtained liquid was concentrated. For phenoxycarbonylation, the obtained liquid was diluted with saturated NH4Cl and extracted with diethyl ether. The organic layer was dried over anhydrous Na2SO4 and then concentrated. The product was obtained by preparative thin-layer chromatography (PTLC) using petroleum ether and ethyl acetate (30:1, v/v) as eluting solvent. The purity of products was checked by NMR and yields were based on aryl iodides. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89.4% | With sulfuric acid; at 80℃; | A solution of 4-acetylbenzoic acid (13.0 g, 79.2 mmol) in ethanol(100 mL) was stirred in ice bath. Concentrated H2SO4 wasslowly added and the mixture was refluxed at 80 C for 3 h.Extracted with EtOAc, washed with saturated brine, dried overanhydrous Na2SO4 and concentrated. The residue was purified bychromatography to afford ethyl 4-acetylbenzoate as a white solid(13.6 g, 89.4%). 1H NMR (400 MHz, DMSO-d6) d 8.06 (m, 4H), 4.35(q, J = 7.1 Hz, 2H), 2.63 (s, 3H), 1.34 (t, J = 7.1 Hz, 3H). MS (ESI, m/z): 191.1 [MH]. |
87% | With graphene oxide; at 100℃; for 24h; | General procedure: A mixture of acid (0.2 mmol), alcohol (0.6 mmol) and GO (50 wt%, calculated with the mass of acid) in ethyl alcohol or DCE (1 mL) was placed in a test tube equipped with a magnetic stirring bar. The mixture was stirred at 100 C for 24 h. After the reaction was finished, filtered the GO, solvent was removed, and the residue was separated by column chromatography to give the pure sample. |
85.4% | With sulfuric acid; at 80℃; for 3h; | A solution of 4-acetylbenzoic acid (10 g, 60.9 mmol) in ethanol (100 mL) was stirred in ice bath. After H2SO4 was slowly added, the mixture was refluxed at 80 C for 3 h. The mixture was extracted with EtOAc, washed with saturated brine, dried (Na2SO4), and concentrated. The residue was purified by chromatography to afford ethyl 4-acetylbenzoate as a white solid (10 g, 85.4%). 1H NMR (400 MHz, CDCl3) delta 8.13-8.09 (m, 2H), 7.99 (dt, J = 6.7, 1.0 Hz, 2H), 4.39 (q, J = 7.1 Hz, 2H), 2.63 (s, 3H), 1.40 (t, J = 7.1 Hz, 3H). MS (ESI, m/z): 193.1 [M+H]+. |
With sulfuric acid; for 8h;Reflux; | General procedure: To a solution of substituted benzoic acid (1-15)(0.246 mol) in dry ethanol (2.5 mol), concentrated sulphuricacid (0.5 mL) was added. The reaction mixture was refluxedfor 8 h. Excess of ethanol was distilled off and the contentwas allowed to cool. The residue was poured into separatingfunnel containing 60 mL of water. Carbon-tetrachloride(5-10 mL) was added to obtain sharp separation of aqueousand ester layer. Ester layer was washed with sodiumhydrogen carbonate solution. The esters (16-30) were collected and recrystallized from ethanol. Details of thesecompounds are available in Supplementary Information. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Reference Example 12; ethyl 4-(3-ethoxy-1-methyl-3-oxopropyl)benzoate; [] Ethyl 4-acetylbenzate (5.00g, 26.0 mmol) was added to a solution (130 ml) of ethyl diethylphosphonoacetate (6.71 ml, 33.8 mmol) and tert-butoxy potassium (4.38g, 39.0 mmol) in tetrahydrofuran at 0C, and the mixture was stirred at room temperature for 16 hrs. Ethyl acetate was added to the reaction mixture, and the mixture was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the obtained residue was purified by NH-silica gel column chromatography (developing solvent; ethyl acetate). The mixture of the obtained oil and 10% palladium carbon (1 g) in ethanol (150 ml) was stirred under a hydrogen atmosphere for 2 hrs, and filtered through celite. The solvent was evaporated under reduced pressure, and the obtained residue was purified by NH-silica gel column chromatography (developing solvent; ethyl acetate) to give the title compound (5.67 g). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68.3% | With acetic acid; In toluene; at 80℃; | A solution of tert-butyl carbazate (14.0 g, 106.1 mmol) andcompound 2 (13.6 g, 70.8 mmol) in toluene (120 mL) with catalyticHOAc was stirred at 80 C overnight. tert-Butyl-2-{1-[4-(ethoxycarbonyl)phenyl]-ethylidene}hydrazine carboxylate was collectedby filtration as a crystalline solid (14.8 g, 68.3%). Without furtherpurification, NaBH3CN (3.3 g, 53.1 mmol) and tert-butyl 2-{1-[4-(ethoxycarbonyl)phenyl]ethylidene}-hydrazinecarboxylate (14.8g, 48.3 mmol) were dissolved in THF (120 mL). A solution of ptoluenesulfonicacid (9.7 g, 56.5 mmol) in THF (50 mL) was slowlyadded for 3 h and the reaction was detected by TLC. The mixturewas extracted with EtOAc and washed with brine, dried over anhydrousNa2SO4 and concentrated to give a white solid. The solid wasredissolved in DCM and washed with 1 N NaOH and the organiclayer was washed with 1 N HCl and brine, dried over Na2SO4 andconcentrated to yield white solid. Flash column chromatographypetroleum ether/ethyl acetate = 4/1 to yield 13.6 g (91%) tert-butyl2-{1-[4-(ethoxycarbonyl)-phenyl]ethyl}hydrazine carboxylate. 1HNMR (400 MHz, DMSO-d6) d 8.17 (s, 1H), 7.89 (d, J = 8.3 Hz, 2H),7.47 (d, J = 8.2 Hz, 2H), 4.73 (s, 1H), 4.30 (q, J = 7.1 Hz, 2H), 4.17(s, 1H), 1.33 (d, J = 6.2 Hz, 9H), 1.30 (d, J = 7.1 Hz, 3H), 1.18 (d, J =6.6 Hz, 3H). MS (ESI, m/z): 307.1 [MH]. |
65.7% | With acetic acid; In toluene; at 80℃; | A solution of tert-butyl carbazate(5.5 g, 41.6 mmol) and ethyl 4-acetylbenzoate (10 g, 52.0 mmol) intoluene (60 mL) with catalytic HOAc was stirred at 80 C overnight.tert-Butyl-2-{1-[4-(ethoxycarbonyl)phenyl]-ethylidene}hydrazinecarboxylate separated as a crystalline solid (10 g, 65.7%) and wascollected by filtration. NaBH3CN (2.4 g, 38.2 mmol) and tert-butyl2-{1-[4-(ethoxycarbonyl)phenyl]ethylidene}-hydrazinecarboxylate(10 g, 32.6 mmol) were dissolved in THF (100 mL). A solutionof p-toluene sulfonic acid (4.3 g, 22.6 mmol) in THF (25 mL) wasslowly added. After stirring the reaction for 3 h, the mixture wasextracted with EtOAc and washed with brine, dried (Na2SO4), andconcentrated to give a white solid. The solid was separated andwashed with 1 N HCl twice and brine twice, dried (Na2SO4), andconcentrated. Product precipitated as white solid and was washedwith petroleum ether/ethyl acetate (4:1) to yield 5.6 g (55.6%) oftert-butyl 2-{1-[4-(ethoxycarbonyl)-phenyl]ethyl}hydrazine carboxylate.1H NMR (400 MHz, CDCl3) d 8.01 (d, J = 8.3 Hz, 2H),7.41 (d, J = 8.3 Hz, 2H), 4.37 (q, J = 7.1 Hz, 2H), 4.22 (d, J = 6.4 Hz,1H), 1.41 (d, J = 2.7 Hz, 9H), 1.38 (d, J = 7.1 Hz, 3H), 1.35 (d,J = 6.6 Hz, 3H). MS (ESI, m/z): 307.1 [MH]. |
In toluene; at 80℃; for 15h; | A solution of tert-butyl carbazate (13.90 g, 105 mmol) and ethyl 4-acetylbenzoate (20.00 g, 0.104 mol) in toluene (120 mL) was stirred at 80 C. overnight (15 h). tert-butyl-2-{1-[4-(ethoxycarbonyl)phenyl]ethylidene}hydrazinecarboxylate separated as crystalline solid and was collected by filtration of the mixture. HPLC/MS: m/z=307.3 (M+1)+, Rt=3.47 min. 1H NMR (500 MHz, CDCl3): delta 8.05 (2H, d, J=8.5 Hz), 7.88 (2H, d, J=8.5 Hz), 7.79 (1H, br s), 4.41 (2H, q, J=7.0 Hz), 2.24 (3H, s), 1.58 (9H, s), 1.43 (3H, t, J=7.0 Hz). |
In toluene; at 80℃; for 15h; | A solution of tert-butyl carbazate (13.90 g, 105 mmol) and ethyl 4-acetylbenzoate (20.00 g, 0.104 mol) in toluene (120 mL) was stirred at 80 0C overnight (15 h). tert-butyl-2-{ l-[4- (ethoxycarbonyl)phenyl]ethylidene}hydrazinecarboxylate separated as crystalline solid and was collected by filtration of the mixture. HPLC/MS: m/z = 307.3 (M+l)+, R1 = 3.47 min. 1H NMR (500 MHz, CDCl3): delta 8.05 (2H, d, J = 8.5 Hz), 7.88 (2H, d, J = 8.5 Hz), 7.79 (IH, br s), 4.41 (2H, q, J = 7.0 Hz), 2.24 (3H, s), 1.58 (9H, s), 1.43 (3H, t, J = 7.0 Hz). | |
In toluene; at 80℃; for 15h; | Step A tert-Butyl 2-{1-[4-(ethoxycarbonyl)phenyl]ethylidene}hydrazinecarboxylate.; A solution of tert-butyl carbazate (13.90 g, 105 mmol) and ethyl 4-acetylbenzoate (20.00 g, 104 mmol) in toluene (120 mL) was stirred at 80 C. overnight (15 h). The title compound separated as crystalline solid and was collected by filtration of the mixture. HPLC/MS: m/z=307.3 (M+1)+, Rt=3.47 min. 1H NMR (500 MHz, CDCl3): delta 8.05 (d, J=8.5 Hz, 2H), 7.88 (d, J=8.5 Hz, 2H), 7.79 (br s, 1H), 4.41 (q, J=7.0 Hz, 2H), 2.24 (s, 3H), 1.58 (s, 9H), 1.43 (t, J=7.0 Hz, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81.6% | With bromine; In aluminium chloride; | EXAMPLE 2 2-(4'-methoxyphenyl)-4-(4"-(N-allyl-N-methylamino-methyl)phenyl]thiazole(VI: R1 =H, R2 =4-MeO, R3 =Me, R4 =allyl) (Process 2, Scheme 2) To a solution of ethyl 4-acetylbenzoate (5.12 g, 26.6 mmol) in ether (50 ml) containing aluminium chloride (0.025 g, 0.19 mmol) is added bromine (1.31 ml, 26.6 mmol) and the reaction mixture is stirred for 2 h. The reaction mixture is poured into saturated NaHCO3 solution and stirred for 30 min. and the layers are separated. The organic layer is washed with NaHCO3, H2 O, dried over MgSO4, concentrated to half of its volume and refrigerated overnight. The resulting solid is filtered to yield ethyl 4-(2'-bromoacetyl) benzoate (5.89 g, 81.6%) as white crystals. 1 H NMR (CDCl3): delta1.42 (t, 3H), 4.42 (q, 2H), 4.48 (s, 3H), 8.04 (d, 2H), 8.16 (d, 2H) |
81% | With copper(ll) bromide; In ethyl acetate; for 16h;Reflux; | To a stirred solution of <strong>[38430-55-6]ethyl-4-acetylbenzoate</strong> (1.85 g, 9.53 mmol) in EtOAc (110 mL), CuBr2 (3.87 g, 17.15 mmol) was added and the mixture stirred at reflux for 16 h. The crude reaction mixture was filtered through a short pad of Celite and concentrated to dryness. Purification by typical silica gel flash chromatography (Cy/CH2C12 from 70:30 to 40:60)afforded the title compound (1.99 g, 8 1%), as a white solid. R= 2.48 mm; MS (ESI) m/z: not detected. ?HNMR (DM50-c/6): oe 8.30-7.94 (m, 4H), 5.00 (s, 2H), 4.36 (q, J= 7.1 Hz, 2H), 1.35 (t, J= 7.1 Hz, 3H) |
81% | With copper(ll) bromide; In ethyl acetate; for 16h;Reflux; | To a stirred solution of <strong>[38430-55-6]ethyl-4-acetylbenzoate</strong> (1.85 g, 9.53 mmol) in EtOAc (110 mL), CuBr2 (3.87 g,17.15 mmol) was added and the mixture stirred at reflux for 16 h. The crude reaction mixture wasfiltered through a short pad of Celite and concentrated to dryness. Purification by typical silica gelflash chromatography (cyclohexane/CH2Cl2 from 70:30 to 40:60) afforded the title compound (1.99 g,81%), as a white solid. Rt = 2.48 min; MS (ESI) m/z: not detected. 1H NMR (DMSO-d6): delta 8.30-7.94(m, 4H), 5.00 (s, 2H), 4.36 (q, 2H, J = 7.1 Hz), 1.35 (t, 3H, J = 7.1 Hz) |
With pyridinium hydrobromide perbromide; hydrogen bromide; acetic acid; In water; at 0 - 20℃; for 1h; | Production Example 2; Synthesis of N-{4-[4-(2-[amino(imino)methyl]amino}ethyl)phenyl]-5-[4-(methylsulfonyl)benzyl]-., 3-thiazol-2-yl}acetamidehydrochloride; Step 1; Ethyl 4-acetylbenzoate (10 g) was dissolved in AcOH(80 ml), and then 90 % pyridinium tribromide (22.2 g) and33 % hydrobromic acid in AcOH (30 ml) were added to thesolution at 0 C. The reaction mixture was stirred at r.t.for 1 hour, and poured into ice-water. The precipitate wascollected in vacuo to give ethyl 4-(bromoacetyl)benzoate(15.1 g) as an off-white solid | |
With bromine; In chloroform; | (a) Ethyl (4-bromoacetyl)benzoate A solution of ethyl 4-acetylbenzoate (1.586 g) in chloroform (50 ml) was stirred at ambient temperature and treated with bromine (0.43 ml). After two hours the resulting solution was evaporated to a solid, which was crystallized from ethanol to give the title benzoate (960 mg); m.p. 73-75. | |
With bromine; In tetrachloromethane; | Example 40 (S)-N-[2-(Benzo[b]thiophen-5-ylmethanesulfonyl)-1-(4-ethoxycarbonylphenyl)ethyl]-N-hydroxyformamide. A stirred solution of ethyl 4-acetylbenzoate (1.92 g) in carbon tetrachloride (20 ml) was treated with bromine (0.51 ml) and heated to 40 C. until the reaction initiated. Heating was then removed and the mixture was stirred for a further 1 h. Removal of the solvent afforded a crude product which was chromatographed (silica gel, 10% EtOAc/hexane) to give ethyl 4-(2-bromoacetyl)-benzoate as a white solid (2.04 g). | |
With aluminum (III) chloride; bromine; In diethyl ether; at 0 - 20℃; for 7.36667h; | A mixture containing ethyl 4-acetylbenzoate (502 mg, 2.61 mmol), AlCl3 (50 mg, 0.37 mmol) in anhydrous ether (5 mL) was cooled in an ice bath under an inert atmosphere of argon. Bromine (0.17 mL, 3.31 mmol) was then added as a solution in ether ( 15 mL) over a period of 10 min. The reaction mixture was slowly allowed to warm to room temperature and stirred for 18 h. The reaction mixture was carefully poured into saturated aqueous NaHCO3 solution and stirred for 30 min. The organic layer was separated and washed successively with dilute aqueous NaHCO3 and H2O. It was then dried (Na2SO4) and concentrated under reduced pressure to afford crude ethyl 4-(2-bromoacetyl) benzoate as a white solid (650 mg). 1H NMR (400MHz, CDCl3) delta: 1.45 (3H, t, J= 7.2 Hz), 4.44 (2 H, q, J= 7.2 Hz), 8.06-8.00 (5H, m). | |
0.44 g | With bromine; In chloroform; at 20℃; for 3h; | To a solution of precursor 18a (0.86 g, 4.48 mmol, 1 equiv) in CHCl3 (30 mL) bromine (0.24 mL, 4.70 mmol, 1.05 equiv) was added dropwise and the reaction mixture stirred 3 h at room temperature. The product was partially purified by washing the organic layer with a saturated Na2S2O3 solution. The solvent was removed under reduced pressure. The crude product was recrystallized in EtOH and the resulting solid (0.44 g, 1.62 mmol, 1 equiv) was dissolved in methanol (25 mL). Thiourea (0.19 g, 2.43 mmol, 1.5 equiv) was added and the reaction was stirred 3 h at room temperature. The solvent was evaporated under reduced pressure. The crude product was suspended in a 5% NaHCO3 solution ande xtracted with dichloromethane (3 × 25 mL). The combined organic layers were dried over anhydrous MgSO4 and the solvent was evaporated under reduced pressure. The crude product was further purified by column chromatography on silica gel (n-hexane-ethyl acetate) to obtain ethyl4-(2-amino-1,3-thiazol-4-yl)benzoate as a slightly yellow solid; overall yield 13 % (0.14 g). 1H-NMR (400.13 MHz, (CD3)2SO) delta: 1.32 (t, 3H, -O-Ethyl-CH3, J = 7.12Hz), 4.31 (q, 2H, -O-Ethyl-CH2, J = 7.10Hz), 7.14 (s, 2H, -NH2), 7.23 (s, 1H, Thiazole-H5), 7.91-7.96 (m, 4H, Ph-H2/3/5/6). 13C-NMR (100.61 MHz, (CD3)2SO) delta: 14.19(-O-Ethyl-CH3), 60.60 (-O-Ethyl-CH2), 104.43 (Thiazole-C5), 125.55 (Ph-C3/5),128.11 (Ph-C1), 129.46 (Ph-C2/6), 139.09 (Ph-C4), 148.74 (Thiazole-C4),165.53 (-COOEt), 168.36 (Thiazole-C2). MS(ESI+): m/e= 249.14 [M+H]+ |
4.40 g | With bromine; In tetrachloromethane; at -10 - 20℃; for 1h; | To the stirred solution of <strong>[38430-55-6]4-acetyl-benzoic acid ethyl ester</strong> (3.0 g, 15.6 mmol) in dry Cd4(150 ml) was added bromine (0.75 ml, 14.8 mmol, in 15 ml Cd4) very slowly at -10 C to 0C. After addition temperature of the reaction mixture was slowly raised to RT and stirred at RT for 1 h. The reaction was monitored by TLC and after completion of the reaction aqueous sodium thiosulphate solution was added to the reaction mixture and was subjected to astandard CH2C12 work up to give 4.40 g of the desired product as a liquid. |
With N-Bromosuccinimide; trimethylsilyl trifluoromethanesulfonate; In acetonitrile; at 40℃; for 5h; | General procedure: Ketone (1 eq) and N-bromosuccinimide (NBS) (2 eq) were solved in acetonitrile and trimethylsilyl trifluoromethanesulfonate (TMS-OTf) (1 eq) was added. The reactions were stirred at T=40C until completeness, diluted with diethyl ether (2ml), washed with H2O (3×2ml), dried over Na2SO4 and concentrated under reduced pressure. This procedure provided bromoketones intermediates in 70-90% overall yield, with purities generally>90% as determined by HPLC-MS. The compounds were used without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 15 Synthesis of 4-{2-[(4-CARBAMOYLPHENYL)AMINO]PYRIMIDIN-4-YL}BENZOIC Acid A mixture of ethyl 4-acetylbenzoate (3.00 g, 15.62 mmol) and N,N-dimethylformamide dimethyl acetal (6.2 g, 52.10 mmol) was refluxed for 18 hours, cooled and concentrated to give ethyl 4-[(2E)-3-(dimethylamino)prop-2-enoyl]benzoate quantitatively. | ||
Example 15 Synthesis of 4-{2-[(4-CARBAMOYLPHENYL)AMINO]PYRIMIDIN-4-YL}BENZOIC ACID A mixture of ethyl 4-acetylbenzoate (3.00 g, 15.62 mmol) and N,N-dimethylformamide dimethyl acetal (6.2 g, 52.10 mmol) was refluxed for 18 hours, cooled and concentrated to give ethyl 4-[(2E)-3-(dimethylamino)prop-2-enoyl]benzoate quantitatively. | ||
Example 15 Synthesis of 4-{2-[(4-Carbamoylphenyl)Amino]Pyrimidin-4-yl}Benzoic Acid A mixture of ethyl 4-acetylbenzoate (3.00 g, 15.62 mmol) and N,N-dimethylformamide dimethyl acetal (6.2 g, 52.10 mmol) was refluxed for 18 hours, cooled and concentrated to give ethyl 4-[(2E)-3-(dimethylamino)prop-2-enoyl]benzoate quantitatively. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With magnesium bromide diethyl etherate; sulfuric acid; ammonium chloride; lithium diisopropyl amide; In THF-hexane; | A. 4-(3-Butyl-5-isoxazolyl)Benzoic Acid Ethyl Ester A solution of ethyl 4-acetylbenzoate (2.93 g, 15.3 mmol) in 25 mL ether was added to a solution of lithium diisopropylamide (0.805 M in THF-hexane, 20.85 mL, 16.79 mmol) in 200 mL of ether at -70 C. The mixture was stirred at -78 C. for 30 minutes, magnesium bromide etherate (3.94 g, 15.26 mmol) was added and the reaction mixture was stirred for 30 minutes followed by the addition of valeryl chloride (1.47 g, 12.2 mmol) in 3 mL ether. Stirring was continued at -78 C. for an additional 30 minutes. The mixture was allowed to come to room temperature, quenched by adding saturated ammonium chloride and acidified (pH=3.0) by adding 20% sulfuric acid. The mixture was extracted with ethyl acetate, the organic layer was dried over magnesium sulfate, concentrated, and the residue subjected to flash chromatography (silica gel/hexane-ethyl acetate 95:5) to afford the title compound (1.35 g). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With trimethylsilyl trifluoromethanesulfonate; triethylamine; In dichloromethane; | Example 201 4-(4-Hydroxy-6-oxo-5-[(2-phenylethyl)thio]-6H-pyran-2-yl)benzoic acid ethyl ester The title compound was prepared by Method A using 4-carboethoxy acetophenone (3 g, 15.61 mmol), trimethylsilyl triflate (3.47 g, 15.61 mmol), triethylamine (3.16 g, 31.22 mmol), methylene chloride (20 mL), and diethyl ester of [2-(phenylethyl)thio]-propanedioic acid (2.31 g, 7.81 mmol). m.p. 156-158 C. 1 H NMR (400 MHz, DMSO-d6) delta1.36 (t, 3H), 2.78 (t, 2H), 3.01 (t, 2H), 4.35 (q, 2H), 6.86 (s, 1H), 7.11-7.28 (m, 5H), 7.92 (d, 2H), 8.08 (d, 2H). | |
With trimethylsilyl trifluoromethanesulfonate; triethylamine; In dichloromethane; | EXAMPLE 201 4-(4-Hydroxy-6-oxo-5-[(2-phenylethyl)thio]-6H-pyran-2-yl)benzoic acid ethyl ester: The title compound was prepared by Method A using 4-carboethoxy acetophenone (3 g, 15.61 mmol), trimethylsilyl triflate (3.47 g, 15.61 mmol), triethylamine (3.16 g, 31.22 mmol), methylene chloride (20 mL), and diethyl ester of [2-(phenylethyl)thio]-propanedioic acid (2.31 g, 7.81 mmol). m.p. 156-158 C. 1 H NMR (400 MHz, DMSO-d6) delta 1.36 (t, 3H), 2.78 (t, 2H), 3.01 (t, 2H), 4.35 (q, 2H), 6.86 (s, 1H), 7.11-7.28 (m, 5H), 7.92 (d, 2H), 8.08 (d, 2H). |
Tags: 38430-55-6 synthesis path| 38430-55-6 SDS| 38430-55-6 COA| 38430-55-6 purity| 38430-55-6 application| 38430-55-6 NMR| 38430-55-6 COA| 38430-55-6 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :